Table 3

Comparison of changes in cardiovascular disease risk between intervention and control groups at 6-month follow-up
N Baseline 6-month Intervention vs. Control
Mean ± S.D. Mean ± S.D. Difference P-valuea
Weight, kg Intervention 251 65.6 ± 8.0 63.7 ± 8.2 -0.93 0.002
Control 1037 65.7 ± 8.3 65.2 ± 8.6
BMI, kg/m2 Intervention 251 25.8 ± 2.2 25.1 ± 2.3 -0.37 0.004
Control 1037 25.6 ± 2.2 25.4 ± 2.4
Waist, cm Intervention 250 90.9 ± 5.9 88.5 ± 6.6 -0.77 0.129
Control 1036 90.3 ± 5.6 89.6 ± 6.3
SBP, mmHg Intervention 251 133.7 ± 14.0 130.8 ± 13.0 -1.77 0.212
Control 1037 134.8 ± 15.5 133.0 ± 15.0
DBP, mmHg Intervention 251 80.0 ± 9.4 77.4 ± 8.7 -1.54 0.092
Control 1036 80.4 ± 10.3 79.3 ± 9.7
HDL-C, mg/dl Intervention 251 57.9 ± 15.2 58.5 ± 15.1 0.91 0.267
Control 1037 56.8 ± 15.1 56.6 ± 15.3
LDL-C, mg/dl Intervention 250 134.7 ± 30.1 130. ± 30.3 2.78 0.227
Control 1036 131.9 ± 30.9 129.4 ± 29.7
TG, mg/dl Intervention 251 141.1 ± 65.8 130.8 ± 71.0 -14.9 0.150
Control 1036 158.8 ± 125.9 148.2 ± 114.3
HbA1c,% Intervention 251 5.33 ± 0.43 5.25 ± 0.38 -0.05 0.179
Control 1033 5.33 ± 0.62 5.33 ± 0.57
Framingham risk score, score Intervention 250 14.0 ± 2.4 13.9 ± 2.4 -0.46 0.002
Control 1029 13.9 ± 2.7 13.9 ± 2.9
Mean 10-year CHD risk, % Intervention 250 9.1 ± 5.9 8.9 ± 6.0 -1.12 0.001
Control 1030 9.4 ± 6.2 9.6 ± 6.5

BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin, CHD = coronary heart disease.

aby covariance analysis adjusted for baseline values, age, sex and intervention times.

Zhu et al.

Zhu et al. BMC Public Health 2013 13:219   doi:10.1186/1471-2458-13-219

Open Data